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Abstract  
Background: This study aimed to characterize and investigate the anti-inflammatory and 
anti-hypernociceptive effects of the total polysaccharide of X. americana (TPL-Xa) bark 
and the of cannabinoid receptors in a mouse model of acute pancreatitis-induced by 
caerulein  
Methods: TPL-Xa was characterized by 1H and 13C RMN spectroscopy. Animals 
received TPL-Xa (10 mg/kg, i.v.) 30 min before and after caerulein (50 μg/kg, 10x, i.p.) 
administration. To evaluate the involvement of cannabinoid receptors, AM281 (3 
mg/kg, s.c.) and AM630 (1 mg/kg, s.c.) were administered 30 min before TPL-Xa. 
Plasma levels of amylase and lipase, pancreatic myeloperoxidase (MPO), histology, 
visceral hypernociception and motor coordination were evaluated 11 and 24 h after 
acute pancreatitis (AP). Results: TPL-Xa, containing a heteropolysaccharide composed 
of glucose, galactose, arabinose, rhamnose, fucose and galacturonic acid, reduced 
amylase and lipase levels, MPO activity, acinar cell necrosis, edema and neutrophil 
infiltration. TPL-Xa increased the threshold of visceral hypernociception, that was 
reversed by AM630, an antagonist of cannabinoid receptors type 2 (CB2). In addition, 
TPL-Xa did not alter the animals motor coordination. 
Conclusions: TPL-Xa contains heteropolysaccharides that inhibits the inflammation and 
hypernociception in the experimental model of caerulein-induced AP, by a mechanism 
involving type CB2 receptors. 
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Acute pancreatitis is an inflammatory pancreas disorder, mainly caused by the 
presence of gallstones and alcohol abuse [1,2]. Its incidence varies from 5 to 80 per 
100.000 individuals per year [3] and is manifested by elevated serum levels of 
pancreatic enzymes and acute pain [4,5]. The pain management is still a major 
challenge, since there are patients refractory to the current therapies, a lack of 
 investigation of visceral pain pathophysiology [6] and side effects of the standard 
treatment with opiates [7].  
The cannabinoid system has emerged as an important antinociceptive pathway, 
since the cannabinoid receptors are distributed in anatomical regions (medulla dorsal 
horn, periaqueductal gray matter) involved in pain transmission and modulation [8]. It 
has been demonstrated that the activation of cannabinoid receptors (CB1, CB2) reduces 
hypernociception in a model of irritable bowel syndrome [9], and in models of acute 
[10–12] and chronic pancreatitis  [13]. These protective effects were also observed in 
vitro models of pancreatic acinar cell injury [14,15]. Consequently, substances that 
interfere with other nociceptive pathways, such as the cannabinoid system, have been 
considered as alternatives for pain modulation [16].  
Plant polysaccharides are molecules known for their modulatory effects on the 
immune system [17], such as inflammation [18,19] and nociception. The 
antinociceptive effects were demonstrated in the mice visceral nociception induced by 
acetic acid for the polysaccharides of Thladiantha dubia [20], Solanum betaceum 
[21,22],  Solanum lycopersicum [23]. In addition, polysaccharide rich fractions isolated 
from Ximenia americana barks,  a plant popularly used as anti-inflammatory and 
analgesic [24,25,26]. Also, in the model of caerulein-induced experimental acute 
pancreatitis the polysaccharide of lemon (low-methoxyl pectin) attenuated the 
inflammatory response and improved intestinal barrier integrity  [27]. The total 
polysaccharides fraction (TPL-Xa: 8.1% yield) presented 43% carbohydrate (21% 
uronic acid) and resulted in two main fractions after chromatography (FI: 12%, FII: 
22% yield). FII showed better homogeneity/purity, content of 44% carbohydrate, 
including 39% uronic acid, arabinoseand galactose as major monosaccharides, and 
infrared spectra with peaks in carbohydrate range for COO−groups of uronic acid [24]. 
This study aimed to analyze the structural features of total polysaccharides of X. 
americana barks and to evaluate their anti-inflammatory and antinociceptive effects in 
the model of acute pancreatitis induced by caerulein in mice. The involvement of 
cannabinoid receptors in their beneficial effects was also evaluated.  
 
2. Materials and Methods  
 
 2.1. Chemicals 
  
  Caerulein and the reagents for dosage of MPO (myeloperoxidase) were obtained 
from Sigma Aldrich (St. Louis, MO-USA); ketamine and 2% xylazine König S/A 
(Hurlingham, Buenos Aires, Argentina); antagonists of cannabinoid receptors CB1 
(AM281) and CB2 (AM630) from Tocris Bioscience (Ellisville, MD, EUA); 
commercial kits for amylase from Labtest (Lagoa Santa, MG, Brazil) and lipase from 
Bioclin (Belo Horizonte, MG, Brazil)  and diazepam from TEUTO S/A (Anápolis, GO, 
Brazil).The remaining drugs and reagents were of analytical grade. 
  
2.2. Polysaccharides extraction and structural characterization 
 
Bark of X. americana L (voucher n° 46794/Herbarium Prisco Bezerra - Federal 
University of Ceará), collected at Custódio- Quixadá, Ceará, Brazil, were washed, dried 
at 40 °C and macerated into powder. Five grams of dry powder were suspended in 
absolute methanol for depigmentation, extraction with 0.1 M NaOH and precipitation in 
ethanol, resulting in the total polysaccharides (TPL-Xa: 8.1% yield, containing 43% 
total carbohydrates, including 21% uronic acid and 6.5% proteins) [24].  
1H and 13C Nuclear Magnetic Resonance (NMR) of TPL-Xa was performed in 
the Fourier transform Bruker Avance DRX 500 spectrometer (USA, California), 
equipped by reverse detection probe, operating at 499.9 MHz (1H) or 125 MHz (13C), in 
the window spectral ratio of 20 ppm for 1H or 200 ppm for 13C. TPL-Xa (32 mg) was 
solubilized in D2O (3%  m/v). The analysis was carried out at 24 ºC and residual water 
signal at 4.79 and chemical shifts () expressed in ppm. 
 
2.3. Animals  
 
Male Swiss mice (20-25 g) were housed in a climate-controlled room and 
maintained at 22-26 °C in a 12 h light/12 h dark cycle, fed with standard chow, water ad 
libitum and allowed to acclimatize for a minimum of 1 week. The experimental 
protocols were approved by the Institutional Animal Care and Use Committee of the 
State University of Ceará (nº 3202316/2014; 06/2014). 
 
2.4. Acute pancreatitis model and treatment with TPL-Xa 
 
 Acute pancreatitis was induced by ten injections of caerulein (50 μg/kg), 
administered by intraperitoneal (i.p.) route at hourly intervals [12]. The control animals 
received saline i.p. Animals were treated with TPL-Xa (10 mg/kg or saline by 
intravenous (i.v.) route 30 min before the first, and 30 min after the last injection of 
caerulein. To evaluate the involvement of cannabinoid receptors in the TPL-Xa effects, 
AM281 (CB1-specific antagonist, 3 mg/kg and AM630 (CB2-specific antagonist, 1 
mg/kg) were administered by subcutaneous (s.c.) route in non-treated or treated animals 
30 min before TPL-Xa. After the 11th and 24th hours following the first injection of 
caerulein, mice were anesthetized (ketamine and 2% xylazine) for collection of blood 
samples and sacrifice. The pancreas was rapidly removed and frozen at -80 °C for 
evaluation of myeloperoxidase activity, or fixed in formalin (10%) for histopathological 
analysis. 
 
2.5. Serum amylase and lipase  
 
Blood samples were taken and centrifuged at 3500 rpm for 10 min. The serum 
amylase and lipase levels were measured by colorimetric method using commercial kits. 
The values of amylase and lipase were expressed as units of enzyme U/dL and U/L, 
respectively. 
 
 2.6. Pancreatic myeloperoxidase activity 
 
Samples of pancreatic tissue were homogenized in 0.5% hexa-decyl-trimethyl-
ammonium bromide (50 mg of tissue/500 µl) and centrifuged (40000 × g, 20 min, 4 ºC). 
Supernatants were incubated in 96-well plates (10 µL) with a mixture of 5 mg O-
dianisidine, 15 µL 1% H2O2, 3 mL phosphate buffer and 27 mL H2O and measured at 
450 nm for 1 min in microplate reader (BMG FLUOstar OPTIMA) [28]. One unit of 
MPO activity was defined as that degrading 1 mmol of peroxide per min at 25 ºC and 
expressed as U/mg of tissue. 
 
2.7. Histopathological analysis 
 
Mice were euthanized at 11 and 24 h after pancreatitis induction. The pancreas 
was excised, fixed with 10% buffered formalin for 24 h, embedded in paraffin, cut into 
 5 µm thick sections and stained with hematoxylin-eosin (HE). The assessment of 
pancreatic edema, inflammatory cell infiltrate and acinar necrosis were graded with 
scores ranging from 0 to 3 [29] under light microscopy. 
  
2.8. Mechanical visceral hypernociception (von Frey test) 
 
Mice were placed in clear acrylic box with raised platforms of wire mesh, 15 
min before the test. The abdominal hypernociceptive reaction (licking of the abdomen, 
abdominal and/or whole-body withdrawal) was evoked by application of a gradual 
pressure (g) using polypropylene tip (0.5 mm2 contact area) coupled to a hand-held 
force transducer (Electronic von Frey Aesthesiometer; Insight). Hypernociception was 
evaluated at baseline (time zero - mean of three measurements) and 11 and 24 h after 
the first dose of caerulein [30].  
 
2.9. Rota-rod test 
 
After 30 min of TPL-Xa treatment, the animals locomotor function was 
assessed. Diazepam (5 mg/kg, i.p.) was used as a positive control. Mice had been 
selected 24 h prior to the test, excluding those that did not remain on the Rota-rod (22 
r.p.m.) for at least two consecutive periods of 60 s. The time in which animals remained 
on the apparatus was recorded [31].  
 
2.10. Western blot analysis  
   
 The Pancreatic tissue was macerated in lysis buffer, after centrifugation, the 
proteins were dosed by the BCA method (Sigma-Aldrich). For immunoblotting, the 
samples were subjected to 10% SDS-PAGE and homogeneous transfer to nitrocellulose 
membranes. Membranes were blocked with TBS-T buffer and 5% milk for 1 h at room 
temperature. For protein detection, blotted membrane was incubated with the specific 
anti-CB2 (1:200; SC) overnight at 4-8º C. Membranes were incubated for one hour at 
room temperature with conjugated secondary antibodies (anti-rabbit, 1:2500; Santa 
Cruz). The blots will be revealed using hemiluminescence technique (ECL plus system).  
 
 
 2.11. Statistical analysis 
 
 Parametric results are presented as mean ± S.E.M and analysed by One-way 
analysis of variance (ANOVA) followed by the Bonferroni t-test. Histological analyses 
were presented as median (maximum and minimum) and analysed by Kruskal-Wallis 
followed by a Dunn test. Values of p<0.05 were considered significant. 
 
3. Results  
 
3.1. 1H and 13C NMR spectra of TPL-Xa 
 The 1H NMR spectra of TPL-Xa revelead a large signal of chemical 
displacement (δ) in 3.83 ppm, attributed to the group -O-CH3, and a minor signal at 
1.17 ppm, suggestive of a methyl group linked to L-fucose monomer  [32]. Other 
signals were also reveled: at 1.25 and 1.31 ppm corresponding to methyl groups of L-
rhamnose unit; at 1.91 ppm indicated the presence of galacturonic acid acetyl groups 
[33] and at 5.40 and 5.25 ppm, corresponding, respectively, to H1 of 
unsubstituted/substituted α-L-arabinose. Besides, signals between 5.09-5.19 ppm are 
possibly related to H1 α-D-glucose and α-D-galactose [32,34,35], and 3.0-4.5 ppm are 
attributed to the hydrogens (H2-H6) of α-D-glucose, α-D-galactose or α-L-arabinose 
[32]. In the 13C NMR spectra, signals at 107.47 and 106.89 ppm possibly correspond to 
anomeric carbons of unsubstituted/substituted α-L-arabinose, respectively, and those at 
99.66 and 95.72 ppm correspond to C1 of the pyranoside ring of α-D-glucose and α-D-
galactose, respectively [32,36]. The signal at 57.38 ppm could be attributed to -O-CH3 
bound to galacturonic acid carboxylate [34]. Signals between 55.0-85.0 ppm could be 
carbon chains (C2-C6) of α-D-glucose, α-D-galactose and α-L-arabinose [35,36], and at 
16.44 ppm attributed to L-fucose. 
 
3.2. Inhibitory effect of TPL-Xa on pancreatic enzymes and inflammatory parameters 
 
 Caerulein induced acute pancreatitis was characterized by a significant increase 
in the levels of serum amylase and lipase at the 11th and the 24th hour after the first 
caerulein injection compared to saline. TPL-Xa reduced the elevated levels of amylase 
at the 11th h by 28.5% (Fig. 2A) and at the 24th h by 26.6%, while lipase levels were 
 reduced only at the 11th h by 52% (Fig. 2B). Caerulein also caused pancreatic tissue 
damage (edema, inflammatory infiltration and acinar cell necrosis) (Fig. 3 A-D) and 
increased MPO activity (Fig. 4). Administration of TPL-Xa markedly reduced the 
histological parameters at the 11th h: edema, inflammatory infiltration, acinar cell 
necrosis and total scores. TPL-Xa reduced the MPO activity by 56% at the 11th h (Fig. 
4A), but caused no alteration at 24th h (Fig. 4B). 
 
3.3. TPL-Xa inhibits visceral hypernociception without alteration of locomotor function 
 
The acute pancreatitis induced by repeated doses of caerulein reduced the 
threshold of nociceptive responses at the 11th h and 24th h. TPL-Xa increased the 
threshold of visceral hypernociception by 42% only at the 11th h after first caerulein 
injection (Fig. 5A). TPL-Xa did not alter the latency of animal permanence in the Rota-
rod. The sedative agent diazepam decreased this latency (Fig. 5B). 
 
3.4. Involvement of CB2 cannabinoid receptors in the anti-hypernociceptive effect of 
TPL-Xa.  
 
The threshold of hypernociception in animals with acute pancreatitis was not 
altered by the administration of selective CB1/CB2 antagonists (Fig. 6B;D). However, 
the administration of AM630 (selective antagonist of CB2 receptors), but not of AM281 
(selective antagonist of CB1 receptors) reversed the TPL-Xa protective effect (Fig. 6 
B;D). In addition, AM 630 reversed the protection of TPL-Xa observed in total 
histopathological scores (Fig. 6E) and the inhibition of CB2 receptor expression (Fig. 
6F). 
Before treatments (time zero of the von Frey test) no differences were observed 
between groups (Fig. 6A;C). 
 
4. Discussion  
 
In this study a heteropolysaccharide was identified in the polysaccharide extract 
obtained from the medicinal plant X. americana barks (TPL-Xa). This 
heteropolysaccharide was shown to be composed of α-D-glucose, α-D-galactose, α-L-
 arabinose, α-rhamnose, L-fucose and galacturonic acid, and reduced the inflammatory 
parameters of caerulein-induced acute pancreatitis in mice.  
The 1H and 13C NMR spectra of TPL-Xa  corroborates other data demonstrated 
by chemical analysis, agarose gel electrophoresis, monosaccharide composition and 
infrared spectra previously showed for the two major polysaccharide rich fractions 
isolated from TPL-Xa. This fractions revealed the presence of uronic acid (8-39%), 
arabinose (39-57%), rhamnose (4-7%), galactose (16-20%) and glucose (7-35%) in its 
monosaccharide composition and infrared spectra demonstrated peaks in carbohydrate 
range for COO- groups of uronic acid [24]. Importantly, some studies have related the 
presence of these acidic compounds of the cell wall of plants with some biological 
activities, such as, antitussive, antioxidant, anti-inflammatory and anticoagulant 
[37,38,39]. Thus, it is possible to speculate that the presence of uronic acid residues 
(21%) in the X. americana heteropolysaccharide may be contributing to the inhibitory 
effect of TPL-Xa on inflammatory parameters of acute pancreatitis induced by cerulein. 
However, additional trials to assess the relationship structure-activity are still required. 
Furthermore, in other studies, phytochemical screening for major constituents for 
ethanol and water extracts of Ximenia americana barks demonstrated also the presence 
of saponins, tannins, flavonoids, alkaloids, phenolics, glycosides, resins, quinones and 
terpenoids [40,41]. 
TPL-Xa protected the inflammatory damage seen by the decrease of histological 
alterations (edema, neutrophil infiltration and acinar necrosis) and MPO activity, a 
common indirect marker of neutrophil infiltration [28] and oxidative stress [42]. The 
model of hyperstimulation of murine exocrine pancreas with caerulein, a 
cholecystokinin analogue, is one of the most widely used and the best characterized 
model of acute pancreatitis due to its high applicability, rapid induction, reproducibility 
and low invasiveness [43]. Hyperstimulation of isolated mouse pancreatic acinar cells 
with cholecystokinin causes sustained cytosolic calcium overload and intracellular 
trypsin activation resulting in cell death [44]. One of the consequences of pancreatic 
enzymatic activation is a local inflammatory response, characterized by oedema and 
neutrophil infiltration, the latter closely associated to the development of caerulein-
induced acute pancreatitis [45]. 
Our data suggest that the protective action of TPL-Xa in pancreatic 
inflammation may particularly involve reduction of neutrophil infiltration, an effect 
already demonstrated for plant polysaccharides [18,19,46,47]. In addition, previous data 
 has demonstrated in mice that the ethanolic extract of X. americana bark reduced cell 
migration in carrageenan-induced peritonitis in mice [48]. These data all together 
support the anti-inflammatory use of X. americana bark in folk medicine [25].  
In the present study, we also demonstrated that TPL-Xa attenuated the visceral 
hypernociception in caerulein-induced AP via mechanisms that involve cannabinoid 
receptors, since the pretreatment with CB2 receptor antagonist (AM630) partially 
reversed the antinociceptive effect of TPL-Xa.  
The cannabinoid system modulates acute and chronic pain from several diseases 
[49,50]. Previous studies suggested the involvement of endocannabinoids in acute 
pancreatitis [12,51]; HU210, a potent central cannabinoid (CB1) and peripheral 
cannabinoid (CB2) receptor agonist, inhibited inflammation and pancreatic 
hypernociception in the caerulein-induced model of AP in mice [12]. Therefore mice 
lacking of CB1 in primary nociceptors developed higher hypernociception to abdominal 
mechanical stimuli after pancreatic inflammation [51]. The CB2 receptor subtype has a 
widespread distribution in the immune system [52], including endocrine and pancreas 
exocrine cells [53] and CB2 receptor agonists have significant antinociceptive actions in 
neuropathic [54] chronic [55] and inflammatory [56] pain models. Additionally, 
activation of CB2 receptors may exert anti-inflammatory effects via reduction of NF- 
κB [57]. However, no specific data are available in exocrine pancreas. In fact, the role 
of the cannabinoid system in the development of AP and the relevance of 
endocannabinoid receptor subtype involvement remains unclear [58]. Consistent with 
the previous study, we found an increase in CB2 expression in pancreatic tissue with 
cerulein-induced AP [12]. In our evaluation, the effect was decreased by the treatment 
with TPL-X and the fate was lost after the treatment with the CB2 receptor antagonist, 
justifying the effect found in the Frey test. 
Despite the importance of pain in pancreatitis, its pathophysiological 
mechanisms are still poorly understood. However, it is recognised that this type of pain 
is characterized as being recurrent, hyperalgesia intense and long-lasting [59] and is 
associated with decrease in the threshold to mechanical stimulation of the abdominal 
region, an area of referred pain [30]. In the present study, TPL-Xa attenuated visceral 
hypernociception induced by pancreatitis in mice, increasing the threshold to 
mechanical stimuli (von Frey test). This action of TPL-Xa on inflammatory pain and 
hypernociception in acute pancreatitis is consistent with the wellknown activities of 
plant polysaccharides in the immune system [60,61], including anti-inflammatory 
 [18,19,62]. Studies in mice have recently demonstrated antinociceptive activities in 
visceral inflammatory pain of crude polysaccharide extracts of Thladiantha dubia 
Bunge [20] and polysaccharides isolated from Solanum betaceum Cav. fruit (tamarillo) 
and Solanum lycopersicum L [21–23].  Furthermore, the inhibitory effect of the aqueous 
extract and polysaccharide fractions of X. americana barks has been previously 
demonstrated in classic models of nociception, including in the visceral nociception 
induced by acetic acid [24,63]. Furthermore, this data is consistent with the popular use 
of X. americana in painful conditions, such as stomachache and headache [25,64].  
It is important to highlight, that the systemic treatment of animals with TPL-Xa 
did not alter locomotor activity, a common adverse side effect of analgesic drugs. 
Therefore, polysaccharides obtained from natural sources represent a structurally 
diverse class of macromolecules known to modulate a variety of biological responses, 
causing low toxicity [17].  
 In conclusion, the total polysaccharides obtained from X. americana bark 
contain a heteropolysaccharide that possesses anti-inflammatory and antinociceptive 
effects in caerulein experimental acute pancreatitis, actions involving cannabinoid type 
2 receptors. 
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L-rhamnose
Fig. 1 NMR of TPL-Xa. 1H (A) and 13C (B). 
 - 2 -
Fig. 2 TPL-Xa reduces pancreatic enzymes. Mice received 10 i.p. injections of caerulein 
(50 μg/kg) or saline at 1 h intervals. TPL-Xa (10 mg/kg) or saline was administered i.v. 30 
min before the first and 30 min after the 10th dose of caerulein. Mice were sacrificed 11 h and 
24 h after the caerulein first injection. Blood samples were taken and the plasma levels of 
amylase (A) and lipase (B) were measured. Mean ± S.E.M. (n = 8). ANOVA and Bonferroni 
test, *p<0.05 compared to caerulein; #p<0.05 compared to saline. 
 - 3 -
Fig. 3 TPL-Xa inhibits histological damage in acute pancreatitis. Mice received 10 i.p. 
injections of caerulein (50 μg/kg) or saline at 1 h intervals. TPL-Xa (10 mg/kg) or saline was 
administered i.v. 30 min before the first and 30 min after the 10th dose of caerulein. Control  
animals received saline (i.p.) instead of caerulein. Mice were sacrificed at 11 h and 24 h after 
the first injection of caerulein for histopathological evaluation: (A) Edema; (B) inflammatory 
infiltration; (C) acinar cell necrosis; (D) total scores. Values are expressed as median 
(maximum and minimum) (n=6). ANOVA, Kruskal-Wallis followed by Dunn test. *p<0.05 
compared to caerulein; #p<0.05 compared to saline. 
 - 4 -
Fig. 4 TPL-Xa inhibits MPO activity in acute pancreatitis. Mice received 10 i.p. injections 
of caerulein (50 μg/kg) or saline at 1 h intervals. TPL-Xa (10 mg/kg) or saline was 
administered i.v. 30 min before the first and 30 min after the 10th dose of caerulein. Control 
animals received saline (i.p.) instead of caerulein. Mice were sacrificed (A) 11 h and (B) 24 h 
after the first injection of caerulein for evaluation of MPO activity. Values are expressed as 
units of MPO (UMPO) per milligram of tissue. Mean ± S.E.M. (n = 8). ANOVA and 
Bonferroni test. *p<0.05 compared to caerulein; #p<0.05 compared to saline.
 - 5 -
Fig. 5 TPL-Xa inhibits visceral hypernociception without alteration of locomotor 
activity. Mice received 10 i.p. injections of caerulein (50 μg/kg) or saline at 1 h intervals. 
TPL-Xa (10 mg/kg, i.v.), saline (i.v.) or diazepam (5 mg/kg, i.p.) was administered 30 min 
before the first and 30 min after the 10th dose of caerulein. (A) Visceral hypernociception was 
evaluated by the von Frey test at the 11th and 24th h after the first injection of caerulein. (B) 
Locomotor function was evaluated at the 11th h in the rota-Rod test. Mean ± S.E.M. (n = 8). 
ANOVA and Bonferroni test. *p<0.05 compared to caerulein; #p<0.05 compared to saline.
 - 6 -
Fig. 6 Involvement of CB2 cannabinoid receptor in the anti-hypernociceptive effect of 
TPL-Xa. Mice received 10 i.p. injections of caerulein (50 μg/kg) or saline at 1 h intervals. (A; 
C) Non-treated animals evaluated at baseline (time zero); (B) Animals pre-treated with saline 
(i.v., TPL-Xa (10 mg/kg; i.v.), AM281 (3 mg/kg, s.c.) or TPL-Xa + AM281; (D, E and F) 
Animals pre-treated with saline (i.v.), TPL-Xa, AM630 (1 mg/kg, s.c.) or TPL-Xa + AM630. 
(D) Withdrawal threshold (E) showing total histological scores, in the photomicrographs 
intense neutrophil infiltrate (red arrow) and necrosis (arrowhead). Hypernociception, 
histological analyses and expression of CB2 was evaluated 11 hours after the first injection of 
caerulein. Photomicrographs of pancreas tissue (100X magnification). Mean ± S.E.M. (n= 8). 
ANOVA and Bonferroni test. *p<0.05 compared to caerulein; #p<0.05 compared to saline 
and (&) p<0.05 compared to TPL-Xa + caerulein.
